small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search

Capabilities 52 results

Industry

Healthcare

Region

Europe

Winston has a well-established presence in Europe representing clients for over three decades. We demonstrate excellence advising clients on transactional, disputes and regulatory matters in the financial services, private equity, industrial, health, and technology sectors. Our European offices bring together a unique blend of deep local knowledge and global expertise, allowing us to effectively navigate complex cross-border legal matters. ...Read more

Practice Area

Government Program Fraud, False Claims Act & Qui Tam Litigation

Investigations and litigation involving alleged fraud against the government pose a significant and growing threat to organizations and individuals across all industries that engage directly or indirectly in business with federal, state, and/or local governments. The government makes aggressive use of its extensive criminal and civil investigatory powers to root out alleged fraud and abuse implicating government funds, including one of its most powerful civil enforcement tools—the federal False Claims Act (FCA)—and similar state false claims statutes....Read more

Experience 40 results

Experience

|

March 30, 2026

Winston advised NextStage AM on its investment in Evoluderm, a leading French player in the hygiene and beauty sector.

Winston & Strawn LLP Paris advised NextStage AM on its investment in Evoluderm, a leading French player in the hygiene and beauty sector. This growth capital transaction, led by NextStage AM as a minority investor, will provide Nathalie and Gabriel Aiach – founders and majority shareholders with over 20 years’ expertise in the cosmetics sector – with the means to accelerate their ambition: to make Evoluderm an iconic brand, ranking among the world leaders in accessible, high-quality beauty. Founded in 2004, Evoluderm has established itself over the last five years as a benchmark in the health and beauty sector, distributed in over 100 countries. The brand has thus experienced remarkable growth, with turnover tripling over the last three years to reach nearly €40 million in 2025. With the support of NextStage AM, Evoluderm is embarking on an ambitious development plan to consolidate its position as a market leader. ...Read more

Experience

|

January 22, 2026

Advised SQM on US$600M offering of subordinated capital notes due 2056 (Hybrid Bond Offering)

Winston & Strawn LLP advised longstanding client Sociedad Química y Minera de Chile S.A. (“SQM”) (NYSE: SQM) on its US$600 million offering of subordinated capital notes. The notes were offered in the United States pursuant to Rule 144A and outside the United States pursuant to Regulation S.The subordinated capital notes are due in 2056 and constitute SQM’s first international hybrid bond issuance, structured to be consistent with SQM’s recent UF 10 million (approximately US$ 430 million) Series S hybrid-subordinated bond issuance in the Chilean securities market. The notes bear an initial annual interest rate of 5.625% and are subject to reset on April 22, 2031 (the “First Reset Date”), and on every fifth anniversary thereafter, based on a spread over the 5-year U.S. Treasury bond rate, with interest rate step-ups on the fifth and twentieth anniversaries of the First Reset Date. The transaction closed on January 22, 2026.BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Santander US Capital Markets LLC, and Scotia Capital (USA) Inc. acted as initial purchasers of the notes.Link Capital Partners was financial advisor to SQM.SQM is a global company with a leading position in the lithium, iodine, and potassium nitrate markets. It develops and produces a diverse range of products for industries essential to human progress, including health, nutrition, renewable energy, and technology, driven by innovation and technological development.The Winston & Strawn team advising on the transaction included corporate partner Sey-Hyo Lee (New York) and foreign legal advisor Bruno M. Fiorino (New York). Partner Katherine Erbeznik (New York) advised on tax matters....Read more

Experience

|

January 5, 2026

Winston advised ODDO BHF “Strategic Opportunities” on its investment in Groupe Hueber Assurances

Winston & Strawn LLP Paris advised ODDO BHF “Strategic Opportunities” on its investment in Groupe Hueber Assurances, a leading player in digital insurance brokerage, notably in health and pet insurance....Read more
View All Experience

Insights & News 1,198 results

Life at Winston

|

April 22, 2026

|

1 Min Read

Winston For Good Heroes: Martha Huffman is a Beneficent Beekeeper, Community Member & Colleague

Giving back to Fate, Texas—the small community where she has lived on her “ranchette” for the past 28 years—is a way of life for Martha. Beekeeping and local politics are simply the latest ways in which she pays her good fortune forward within Fate.

False Claims Act Playbook

|

March 23, 2026

|

9 Min Read

Alabama Court Dismisses Hospice Whistleblower Suit, Reinforcing Pleading Standards and First-to-File Protections Under the FCA

On February 19, 2026, the United States District Court for the Middle District of Alabama dismissed a declined qui tam whistleblower suit brought against Comfort Care Hospice, LLC, and several related hospice and home health service providers based in Alabama and Tennessee, claiming improper billing practices in violation of the False Claims Act and the Tennessee Medicaid False Claims Act.

False Claims Act Playbook

|

March 23, 2026

|

10+ Min Read

Future FCA Enforcement Expectations in Light of Record-Breaking FY 2025 Recoveries and Administration Priorities

The annual False Claims Act (FCA) recovery statistics issued by the U.S. Department of Justice (DOJ) for Fiscal Year 2025 represent the highest single-year recovery in FCA history, underscoring that the FCA remains one of the government’s most effective tools for combating frauds involving federal funds. Winston attorneys outline expectations for FCA enforcement in 2026 and beyond based on an analysis of FY 2025 FCA activity and the priorities and goals of the current administration.

View All Insights & News

Other Results 39 results

Site Content

What Is Healthcare Security Law?

The Health Insurance Portability and Accountability Act of 1996 (HIPAA) established U.S. regulations to protect the privacy and security of individual health information. The healthcare security law creates these specific protections through both the HIPAA Privacy Rule and the HIPAA Security Rule. The Privacy Rule has set national standards for the protection of certain types of health information. The Security Rule established security standards for protecting consumers’ health information that is stored or transferred electronically. The healthcare Security Rule outlines the operational safeguards that organizations must implement to keep protected electronic health information secure....Read more

Site Content

What Is Healthcare Privacy Law?

Today, healthcare privacy law is driven by the 1996 Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule. This federal privacy rule establishes protections for specific patient health information. Healthcare plans, clearinghouses, and providers are subject to the law....Read more

Site Content

Japan Practice

Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2026. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising